Abstract:Objective To investigate the clinical features, treatment strategies and prognoses of primary Ewing’s sarcoma of the sacrum. Methods The data of 15 patients with primary Ewing’s sarcoma of the sacrum who were adopted from June 1998 to June 2011 were retrospectively analyzed. There were 9 males and 6 females, whose average age was 18 years old ( range;11-45 years ). All the patients had sacrococcygeal pain, and 11 patients had perineal numbness and pain in the lower extremities. Three patients had palpable masses. The single segment was invaded in 2 cases, and double or more segments were invaded in 13 cases. The preoperative X-ray iflms and CT scans indicated that there was much irregular osteolytic bone destruction in the sacral vertebra. The CT and MRI examination often showed huge soft tissue masses. The systemic chemotherapy and surgical treatment were performed on all the patients, and the radiotherapy on 10 patients postoperatively. Nine patients underwent block resection of sacral tumors and reconstruction, and 6 patients underwent en bloc resection, among whom 4 patients received one-stage total sacrectomy by a combined anterior-posterior approach and rod-screw reconstruction. Results All patients were followed up for an average period of 5.2 years ( range, 2-10 years ). The local pain in all the patients got relieved. Five patients had perioperative complications and 4 of them had wound healing problems. Eleven patients had bladder and bowel dysfunction in varying degrees. During the follow-up, 10 cases of local recurrence and metastasis were found. The local recurrence rate was 60%( 9/15 ) and the lung metastasis rate was 33.3%( 5/15 ), including 4 cases of both local recurrence and lung metastasis. Among the 6 patients treated by en bloc resection, 1 patient had local recurrence in the sacrum and 1 patient had both local recurrence and lung metastasis. The duration of metastasis and local recurrence was 7-60 months. The 10 patients who had local recurrence and lung metastasis received the second-line chemotherapy. Nine patients died in the latest follow-up, and 2 patients survived with tumors. The 2-year and 5-year disease-free survival rate were 60%and 33.3%respectively. The 5-year overall survival rate was 47%. Conclusions The primary Ewing’s sarcoma of the sacrum is highly malignant, for which the comprehensive therapy including the surgery, radiotherapy and chemotherapy is necessary. The en bloc resection of sacral tumors is an important local treatment method for primary malignant tumors in spite of many complications.

The treatment and prognosis of primary spinal Ewing′s sarcoma family tumor

Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.

[Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].

[Ewing's Sarcoma of Bone:Treatment Results and Prognostic Factors].

Clinical analysis of primary Ewing’s sarcoma of the sacrum：15 cases report

Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience

Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors

Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors

Advances in Chemotherapy and Radiotherapy Combined with Molecular Targeted Therapy for Ewing's Sarcoma

Prognostic factors for local and distant control in Ewing sarcoma family of tumors

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience

Ewing's Sarcoma Family of Tumors: Current Management

Therapy for localized Ewing's sarcoma of bone

Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy

Prognostic factors and outcome of relapsed/progressive pediatric Ewing sarcoma: single-center 10-year experience

Imaging findings of the spinal peripheral Ewing's sarcoma family of tumours.

Advances in multi-therapies for the treatment of Ewing's sarcoma

Recurrent Intracranial Ewing Sarcoma

Current Status of Management and Outcome for Patients with Ewing Sarcoma

Sacral Ewing sarcoma with rib, lung, and multifocal skull metastases: A rare case report and review of treatments

Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma